Core B - Mutant Mouse
Core B - Mutant Mouse
批准号:
10670292
负责人:
Dario AA Vignali
金额:
$47.39万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
未结题
起止时间:
2015-05-15 至 2025-07-31
中文摘要
核心摘要
突变小鼠核心(核心B)是一个必不可少的核心,将被所有三个项目广泛使用。给定
多种细胞类型上不同抑制性受体之间的复杂相互作用,这是人们可以分析
这些关键的疾病相关的生物学问题在体内是与复杂的小鼠模型。显著
这种PPG应用的优势在于它将使用的独特的“免疫工具箱”,特别是PD 1/LAG 3
floxed小鼠与独特的谱系特异性的集合相结合,并且在大多数情况下是暂时控制的,
Cre重组酶表达小鼠。这些工具将给我们前所未有的控制,从而洞察
PD 1/LAG 3在多种细胞类型中的协同作用和功能。
目的1:提供所需的PD 1/LAG 3突变小鼠。核心将由大学管理,
匹兹堡(Pitt),大部分突变小鼠育种和采购外包给Taconic,
无鼠病原体屏障条件与其大多数商业育种实践相同。Taconic
将使用其传统的递送机制,每两周轮换一次将小鼠递送到所有研究地点,
从而避免长时间的隔离。
目的2:产生新的突变小鼠组合。核心将产生新的突变小鼠
引入不同遗传元件的组合,例如新的Cre菌株。
PPG互动:核心B将广泛支持项目1、项目2和项目3,并与核心互动
提供方便的育种,运输和基因分型数据。核心B也将进行额外的杂交
以生成项目所需的任何应变组合。核心B将与核心A交互,以提供简单的
获取育种、运输和基因分型数据,并进行持续监测。
英文摘要
CORE SUMMARY
The Mutant Mouse Core (Core B) is an essential core that will be used extensively by all three projects. Given
the complex interplay between different inhibitory receptors on multiple cell types, the only way one can dissect
these critical disease-related biological questions in vivo is with sophisticated mouse models. A significant
strength of this PPG application is the unique ‘immunological toolbox’ that it will utilize, specifically PD1/LAG3
floxed mice combined with a unique collection of lineage-specific, and in most instances temporally controlled,
Cre recombinase-expressing mice. These tools will give us unprecedented control and thus insight into
PD1/LAG3 synergy and function in multiple cell types.
AIM 1: To provide required PD1/LAG3 mutant mice. The Core will be administered from the University of
Pittsburgh (Pitt), with the majority of the mutant mouse breeding and procurement outsourced to Taconic under
Murine Pathogen Free barrier conditions identical to the majority of their commercial breeding practices. Taconic
will deliver mice to all research sites on a rotating bi-weekly basis using their conventional delivery mechanism,
thereby avoiding lengthy quarantine.
AIM 2: To generate new mutant mouse combinations. The Core will generate new mutant mouse
combinations that introduce different genetic elements such as new Cre stains.
PPG Interactions: Core B will support Project 1, Project 2 and Project 3 extensively, and interact with Core
A to provide easy access to breeding, shipping and genotyping data. Core B will also perform additional crosses
to generate any strain combinations required by the projects. Core B will interact with Core A to provide easy
access to breeding, shipping and genotyping data and ongoing monitoring.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulatory T cells and the tumor microenvironment
-
批准号:10454307
-
项目类别:
-
资助金额:$90.64万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10683756
-
项目类别:
-
资助金额:$36.97万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10469635
-
项目类别:
-
资助金额:$37.8万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Regulatory T cells and the tumor microenvironment
-
批准号:10298246
-
项目类别:
-
资助金额:$92.79万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Regulatory T cells and the tumor microenvironment
-
批准号:10670939
-
项目类别:
-
资助金额:$90.64万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
-
批准号:10270231
-
项目类别:
-
资助金额:$36.39万
-
财政年份:2021
-
负责人:Dario AA Vignali
-
依托单位:
Interleukin-35 and the tumor microenvironment
-
批准号:9306799
-
项目类别:
-
资助金额:$38.03万
-
财政年份:2016
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10670296
-
项目类别:
-
资助金额:$44.51万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10239106
-
项目类别:
-
资助金额:$17.39万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10023664
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
-
批准号:10470821
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10663572
-
项目类别:
-
资助金额:$15.35万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:8854453
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core B - Mutant Mouse
-
批准号:10023665
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10239112
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer and antiviral immunity
-
批准号:8854446
-
项目类别:
-
资助金额:$222.34万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
-
批准号:10670290
-
项目类别:
-
资助金额:$231.17万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
-
批准号:10663577
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core B - Mutant Mouse
-
批准号:10663573
-
项目类别:
-
资助金额:$47.59万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
Core A - Administrative Core
-
批准号:10670291
-
项目类别:
-
资助金额:$13.27万
-
财政年份:2015
-
负责人:Dario AA Vignali
-
依托单位:
海外基金